Skip to content
Nonprofiteer
← FAMILIES OF SMA

Form 990 for tax year 2024

Filed by FAMILIES OF SMA.

Totals

Total revenue
$15,213,970
Total expenses
$14,019,399
Contributions and grants received
$7,673,243
Grants paid
$2,564,862
Program service revenue
$6,912,298
Investment income
$209,381
Other revenue
$419,048
Total assets, end of year
$10,645,251
Total liabilities, end of year
$3,222,762
Net assets or fund balances, end of year
$7,422,489
Program services expenses (Part IX)
$10,840,169
Management and general expenses
$1,300,650
Fundraising expenses
$1,878,580
Program service expenses (Part III)
$10,840,169

Program services were 77.3% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1c , Fundraising events

    $2,630,216

  • 1f , All other contributions, gifts and grants

    $5,043,027

  • 1g , Noncash contributions included above

    $126,484

  • 2a , Program service revenue: ANNUAL CONFERENCE

    total $4,504,249 · related or exempt $4,504,249

  • 2b , Program service revenue: INDUSTRY SPONSORED RESEARCH

    total $1,593,049 · related or exempt $1,593,049

  • 2c , Program service revenue: SUMMIT OF STRENGTH SYMPOSIUMS

    total $815,000 · related or exempt $815,000

  • 3 , Investment income

    total $152,824 · excluded $152,824

  • 7a , Gross sales of assets other than inventory

    securities $476,058

  • 7b , Less cost or other basis and sales expenses

    securities $419,501

  • 7c , Gain or loss

    securities $56,557

  • 7d , Net gain or loss

    total $56,557 · excluded $56,557

  • 8a , Fundraising events: gross income

    $709,219

  • 8a , Fundraising events: contributions included on line 1c

    $2,630,216

  • 8b , Fundraising events: direct expenses

    $604,578

  • 8c , Net income from fundraising events

    total $104,641 · excluded $104,641

  • 11a , Other revenue: HOTEL COMMISSIONS

    total $159,514 · related or exempt $159,514

  • 11b , Other revenue: LEASE CANCELLATION

    total $112,500 · related or exempt $112,500

  • 11c , Other revenue: STORE MERCHANDISE

    total $24,454 · related or exempt $24,454

  • 11d , All other revenue

    total $17,939 · related or exempt $17,939

  • 11e , Other revenue, total

    $314,407

Functional expenses

Part IX, the statement of functional expenses.

  • 1 , Grants to domestic organizations and governments

    total $1,802,574 · program services $1,802,574

  • 2 , Grants to domestic individuals

    total $196,619 · program services $196,619

  • 3 , Grants to foreign organizations and individuals

    total $565,669 · program services $565,669

  • 5 , Compensation of officers, directors and key employees

    total $1,168,801 · program services $541,662 · management and general $188,361 · fundraising $438,778

  • 7 , Other salaries and wages

    total $3,747,629 · program services $2,323,971 · management and general $552,700 · fundraising $870,958

  • 8 , Pension plan contributions

    total $98,683 · program services $62,575 · management and general $14,285 · fundraising $21,823

  • 9 , Other employee benefits

    total $319,066 · program services $194,954 · management and general $45,848 · fundraising $78,264

  • 10 , Payroll taxes

    total $348,964 · program services $204,319 · management and general $52,414 · fundraising $92,231

  • 11b , Fees: legal

    total $4,425 · management and general $4,425

  • 11c , Fees: accounting

    total $36,050 · management and general $36,050

  • 11f , Fees: investment management

    total $18,750 · management and general $18,750

  • 11g , Fees: other

    total $550,314 · program services $527,293 · management and general $5,371 · fundraising $17,650

  • 12 , Advertising and promotion

    total $33,092 · program services $23,820 · management and general $4,806 · fundraising $4,466

  • 13 , Office expenses

    total $384,534 · program services $324,550 · management and general $18,238 · fundraising $41,746

  • 14 , Information technology

    total $451,247 · program services $315,874 · management and general $31,586 · fundraising $103,787

  • 16 , Occupancy

    total $123,018 · program services $72,028 · management and general $18,476 · fundraising $32,514

  • 17 , Travel

    total $204,728 · program services $119,869 · management and general $30,749 · fundraising $54,110

  • 19 , Conferences, conventions and meetings

    total $3,412,351 · program services $3,268,889 · management and general $115,465 · fundraising $27,997

  • 22 , Depreciation, depletion and amortization

    total $135,755 · program services $120,930 · management and general $5,372 · fundraising $9,453

  • 23 , Insurance

    total $43,929 · program services $19,130 · management and general $16,163 · fundraising $8,636

  • 24a , Other expenses: BANK CHARGES, CREDIT CA

    total $127,631 · management and general $87,298 · fundraising $40,333

  • 24b , Other expenses: WEBSITE

    total $114,664 · program services $85,998 · management and general $5,733 · fundraising $22,933

  • 24c , Other expenses: PROMOTIONAL ITEMS

    total $41,402 · program services $37,245 · management and general $4,157

  • 24d , Other expenses: DUES AND SUBSCRIPTIONS/

    total $28,910 · program services $11,475 · management and general $10,338 · fundraising $7,097

  • 24e , All other expenses

    total $60,594 · program services $20,725 · management and general $34,065 · fundraising $5,804

Balance sheet

Part X, book values.

  • 1 , Cash, non-interest-bearing

    beginning of year $3,808,783 · end of year $4,762,767

  • 3 , Pledges and grants receivable

    beginning of year $4,000,444 · end of year $3,183,431

  • 9 , Prepaid expenses and deferred charges

    beginning of year $223,881 · end of year $226,893

  • 10a , Land, buildings and equipment: cost or other basis

    $855,101

  • 10b , Land, buildings and equipment: accumulated depreciation

    $796,016

  • 10c , Land, buildings and equipment, net

    beginning of year $161,593 · end of year $59,085

  • 11 , Investments: publicly traded securities

    beginning of year $2,291,309 · end of year $2,391,493

  • 14 , Intangible assets

    beginning of year $33,647 · end of year $1,588

  • 15 , Other assets

    beginning of year $184,311 · end of year $19,994

  • 17 , Accounts payable and accrued expenses

    beginning of year $2,962,429 · end of year $1,842,564

  • 18 , Grants payable

    beginning of year $1,245,367 · end of year $1,201,221

  • 25 , Other liabilities

    beginning of year $374,843 · end of year $178,977

  • 27 , Net assets without donor restrictions

    beginning of year $1,424,129 · end of year $2,609,833

  • 28 , Net assets with donor restrictions

    beginning of year $4,697,200 · end of year $4,812,656

Mission and programs · 2024

Mission

OUR MISSION IS TO DRIVE RESEARCH FOR TREATMENTS AND A CURE FOR SMA, AND TO SUPPORT AND EMPOWER EVERYONE IMPACTED BY SMA TODAY.

Activities or mission (Part I)

TO DRIVE RESEARCH FOR TREATMENTS AND A CURE FOR SMA, AND TO SUPPORT AND EMPOWER EVERYONE IMPACTED BY SMA TODAY.

  • INDIVIDUALS WITH SMA NEED SPECIALIZED CARE AND EQUIPMENT, WHICH CAN PUT ENORMOUS LOGISTICAL AND FINANCIAL PRESSURE ON FAMILIES. CURE SMA IS COMMITTED TO MAKING SURE THAT FAMILIES HAVE THE BEST, MOST ACCURATE INFORMATION ABOUT SMA AND WHAT IT MEANS FOR THEM, AND TO MAKING SURE THAT THEY UNDERSTAND ALL THE OPTIONS AND RESOURCES AVAILABLE TO THEM FROM DAY-TO-DAY CARE TO THE CHANGING LANDSCAPE OF RESEARCH BREAKTHROUGHS AND TREATMENTS. THIS INCLUDES OUR CARE SERIES BOOKLETS, WHICH ARE SENT OUT AS PART OF INFORMATIONAL PACKETS AVAILABLE AT NO COST TO ANYONE WHO REQUESTS ONE. DEVELOPED BY MEDICAL EXPERTS AND REVIEWED BY FAMILIES, THESE BOOKLETS COVER TOPICS SUCH AS BREATHING, NUTRITION, PALLIATIVE CARE, GENETICS, MUSCULOSKELETAL ISSUES, AND MORE. IN ADDITION, OUR EQUIPMENT POOL GIVES FAMILIES ACCESS TO SPECIALIZED ITEMS LIKE CAR BEDS, STROLLERS AND BATHING SYSTEMS AT NO COST. EVERY NEWLY-DIAGNOSED FAMILY RECEIVES A CARE PACKAGE FROM CURE SMA, FULL OF TOYS APPROPRIATE TO THE CHILD'S TYPE OF THE DISEASE, IMPARTIAL INFORMATION FOR PARENTS, AND USEFUL ITEMS SUGGESTED BY OTHER SMA PARENTS BASED ON THEIR OWN EXPERIENCES. EVERY NEW ADULT TO THE COMMUNITY RECEIVES A PACKAGES OF SPECIAL INDEPENDENCE RELATED ITEMS.CURE SMA ALSO EDUCATES THE PUBLIC ABOUT SMA, TO STRENGTHEN THE SUPPORT AVAILABLE TO FAMILIES. THIS INCLUDES DIRECTIONS, A BIANNUAL FAMILY SUPPORT NEWSLETTER, AND COMPASS, A QUARTERLY UPDATE ON RESEARCH DEVELOPMENTS

    Expenses $4,835,026 · Grants $196,619 · Revenue $245,468

  • CURE SMA FOCUSES ON THREE DIFFERENT YET EQUALLY CRITICAL AND INTERDEPENDENT RESEARCH AREAS: BASIC RESEARCH, TO UNDERSTAND THE CAUSE AND BIOLOGY OF SMA; DRUG DISCOVERY, TO CONVERT BASIC RESEARCH IDEAS INTO PRACTICAL NEW DRUG CANDIDATES; AND CLINICAL & REGULATORY RESEARCH, TO PROVIDE THE INFRASTRUCTURE TO TEST THE DRUG CANDIDATES. DURING THIS PERIOD CURE SMA FUNDED SIX NEW AND SIX ONGOING BASIC RESEARCH GRANTS. WE ALSO FUNDED AND EXECUTED MULTIPLE CLINICAL AND REGULATORY FOCUSED PROJECTS, TO INCREASE SMA CLINICAL TRIAL SITE CAPACITY AND READINESS, TO PROVIDE REGULATORY AUTHORITIES WITH DATA ON THE SMA POPULATION AND THEIR REPORTED UNMET NEEDS, AND TO COLLECT DATA TO UNDERSTAND THE PATIENT EXPERIENCE WITH SMA. CURRENTLY, THERE ARE THREE APPROVED DRUGS FOR SMA, WITH ANOTHER SEVERAL DOZEN DRUG PROGRAMS IN DEVELOPMENT, INCLUDING FIVE IN CLINICAL TRIALS. CURRENTLY, TWO INVESTIGATIONAL DRUGS ARE AWAITING FDA APPROVAL.CURE SMA HAVE THREE PRIMARY DATABASES FOR DATA COLLECTION: A PATIENT-REPORTED DATABASE WITH DATA FROM OVER 11,000 IMPACTED INDIVIDUALS WORLDWIDE THAT ALSO INCORPORATES LONGITUDINAL DATA FROM OUR ANNUAL COMMUNITY UPDATE SURVEY; THE SMA CLINICAL DATA REGISTRY (CDR) THAT CONTAINS ELECTRONIC MEDICAL RECORD (EMR) SOURCED DATA FROM U.S. BASED SMA CARE CENTER NETWORK SITES; AND THE NEWBORN SCREENING REGISTRY WITH DATA FROM PARENTS OF BABIES WITH SMA THAT WERE IDENTIFIED THROUGH STATEWIDE SMA NEWBORN SCREENING. THE ABOVE DATA SOURCES ARE COMBINED AND ANALYZED ANNUALLY TO IDENTIFY TRENDS IN DEMOGRAPHICS, DIAGNOSIS, SMA TREATMENTS, UNMET NEEDS, PATIENT CARE AND OUTCOMES. THE MOST RECENT ANALYZES WERE PUBLISHED IN THE STATE OF SMA 2024 REPORT AVAILABLE ON OUR WEBSITE. DATA COLLECTED IS ALSO SHARED IN PEER-REVIEWED LITERATURE. CURE SMA PUBLISHED "SMA COMMUNITY PRIORITIES FOR FUTURE DRUG THERAPIES: CROSS-SECTIONAL SURVEY FINDING REPRESENTING 410 ADULTS WITH SMA" IN NEUROLOGY AND THERAPY IN JUNE 2025. IN ADDITION, CURE SMA SUPPORTS THE SMA INDUSTRY COLLABORATION. ESTABLISHED IN 2016, THE COLLABORATION IS A MULTI-FACETED PARTNERSHIP THAT BRINGS TOGETHER PHARMACEUTICAL COMPANIES, CURE SMA, AND OTHER NONPROFIT ORGANIZATIONS TO SHARE INFORMATION, IDEAS, AND DATA. THE SMA INDUSTRY COLLABORATION WORKS TOGETHER TO ADDRESS SCIENTIFIC, CLINICAL, AND REGULATORY TOPICS THAT ARE CRITICAL TO ADVANCING DRUG DEVELOPMENT IN SMA AND WILL BENEFIT THE BROADER SMA COMMUNITY. CURE SMA CO-CREATED A NEW HEALTHCARE PROVIDER ENDURING CONTINUING MEDICAL EDUCATION PROGRAM IN ADDITION TO THE IN-PERSON CURE SMA CLINICAL CARE SESSION OFFERED IN JUNE 2025. RESOURCES WERE ALSO DEVOTED TO MAINTAINING WEBSITE LISTINGS OF SMA NEWBORN SCREENING REFERRAL CENTERS AND TREATMENT CENTERS THAT PROVIDE FDA-APPROVED SMA TREATMENTS.

    Expenses $5,416,203 · Grants $2,368,243 · Revenue $1,650,318

  • WE HOSTED THE 2025 ANNUAL SMA CONFERENCE IN ANAHEIM, CA WITH OVER 2,739 REGISTERED ATTENDEES. OUR ANNUAL CONFERENCE IS AN INVALUABLE RESOURCE FOR THE ENTIRE SMA COMMUNITY. THE CONFERENCE IS THE LARGEST IN THE WORLD FOCUSED SPECIFICALLY ON SMA. THE RESEARCHER AND CLINICAL CARE CONFERENCE ATTRACTED THE TOP SCIENTISTS AND COMPANIES IN THE FIELD. THE COMMUNITY CONFERENCE INCLUDES A VARIETY OF WORKSHOPS, KEYNOTE SESSIONS WITH LEADING EXPERTS, AND MORE-PLUS GREAT EVENTS SUCH AS OUR TEEN AND ADULTS WITH SMA SOCIALS, THE FAMILY FRIENDLY RESEARCHER POSTER SESSION AND OUR MEET & GREET, WITH A FAMILY FUN FEST. THE RESEARCHER AND CLINICAL CARE CONFERENCE CREATES OPEN COMMUNICATION OF EARLY, UNPUBLISHED SCIENTIFIC DATA, ACCELERATING THE PACE OF RESEARCH. THE MEETING ALSO FURTHERS RESEARCH BY BUILDING PRODUCTIVE COLLABORATIONSINCLUDING CROSS-DISCIPLINARY DIALOGUE, PARTNERSHIPS, INTEGRATION OF NEW RESEARCHERS AND DRUG COMPANIES, AND EDUCATIONAL OPPORTUNITIES FOR JUNIOR RESEARCHERS. COMMUNITY ATTENDEES HAVE DIRECT ACCESS TO THE LATEST INFORMATION ABOUT RESEARCH, AND RESEARCHERS HAVE AN OPPORTUNITY TO BUILD PERSONAL CONNECTIONS WITH THE PATIENTS WHO WILL BENEFIT FROM THEIR WORK.

    Expenses $588,940 · Revenue $5,330,919

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Robert Graham

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Peter Statile

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Mark Moore

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Marc Ginsky

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Karen McRoy-Negrin

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Bakri Elsheikh

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Joe Wiseman

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Rob Lockwood

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Kelly Jankowski

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Amy Medina

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Gillian Mullins

    DIRECTOR (THROUGH 12/31/24)

    Total calculated
    $0
    Hours/week
    2
  • Edmund Lee

    DIRECTOR (THROUGH 12/31/24)

    Total calculated
    $0
    Hours/week
    2
  • Diana Castro

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Brian Snyder

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Brianna Gross

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Jaclyn Greenwood

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Corey Braastad

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Allyson Henkel

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Collin Pollock

    DIRECTOR (START 4/26/25)

    Total calculated
    $0
    Hours/week
    2
  • Rachel Brown

    DIRECTOR (START 4/26/25)

    Total calculated
    $0
    Hours/week
    2
  • Tyler Dukes

    DIRECTOR (START 4/26/25)

    Total calculated
    $0
    Hours/week
    2
  • Kaleen Robinson

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Spencer Perlman

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Nick Farrell

    BOARD CHAIR

    Total calculated
    $0
    Hours/week
    5
  • Bradley A Nunemaker

    TREASURER & VICE CHAIR

    Total calculated
    $0
    Hours/week
    5
  • Shannon Zerzan

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • John Weber

    DIRECTOR (START 10/1/2024)

    Total calculated
    $0
    Hours/week
    2
  • Kenneth Hobby

    PRESIDENT

    Total calculated
    $348,806
    From this org
    $329,195
    From related orgs
    $0
    Other
    $19,611
    Hours/week
    70

    Schedule J breakdown matched by us

    Base
    $329,195
    Bonus
    $0
    Other
    $0
    Deferred
    $12,244
    Nontaxable benefits
    $7,367
    Filer's total
    $348,806
  • Jamie Gibson

    CHIEF DEVELOPMENT OFFICER

    Total calculated
    $294,579
    From this org
    $266,038
    From related orgs
    $0
    Other
    $28,541
    Hours/week
    60

    Schedule J breakdown matched by us

    Base
    $266,038
    Bonus
    $0
    Other
    $0
    Deferred
    $9,619
    Nontaxable benefits
    $18,922
    Filer's total
    $294,579
  • Mary Schroth

    CHIEF MEDICAL OFFICER (THROUGH 3/31/25)

    Total calculated
    $228,544
    From this org
    $218,342
    From related orgs
    $0
    Other
    $10,202
    Hours/week
    60

    Schedule J breakdown matched by us

    Base
    $218,342
    Bonus
    $0
    Other
    $0
    Deferred
    $8,841
    Nontaxable benefits
    $1,361
    Filer's total
    $228,544
  • Marline Pagan

    CHIEF OPERATING OFFICER

    Total calculated
    $239,457
    From this org
    $208,905
    From related orgs
    $0
    Other
    $30,552
    Hours/week
    60

    Schedule J breakdown matched by us

    Base
    $208,905
    Bonus
    $0
    Other
    $0
    Deferred
    $9,202
    Nontaxable benefits
    $21,350
    Filer's total
    $239,457
  • Jesse Aynes

    VICE PRESIDENT OF DEVELOPMENT

    Total calculated
    $145,118
    From this org
    $135,299
    From related orgs
    $0
    Other
    $9,819
    Hours/week
    50
  • Mary Curry

    VICE PRESIDENT, CLINICAL RESEARCH & CARE

    Total calculated
    $158,715
    From this org
    $138,474
    From related orgs
    $0
    Other
    $20,241
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $138,474
    Bonus
    $0
    Other
    $0
    Deferred
    $6,111
    Nontaxable benefits
    $14,130
    Filer's total
    $158,715
  • Maynard Friesz

    VICE PRESIDENT, POLICY

    Total calculated
    $163,143
    From this org
    $149,595
    From related orgs
    $0
    Other
    $13,548
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $149,595
    Bonus
    $0
    Other
    $0
    Deferred
    $5,879
    Nontaxable benefits
    $7,669
    Filer's total
    $163,143
  • Jackie Glascock

    VICE PRESIDENT OF RESEARCH

    Total calculated
    $153,657
    From this org
    $146,346
    From related orgs
    $0
    Other
    $7,311
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $146,346
    Bonus
    $0
    Other
    $0
    Deferred
    $6,067
    Nontaxable benefits
    $1,244
    Filer's total
    $153,657
  • Colleen McCarthy O'Toole

    SR VICE PRESIDENT, COMMUNI

    Total calculated
    $202,496
    From this org
    $175,435
    From related orgs
    $0
    Other
    $27,061
    Hours/week
    60

    Schedule J breakdown matched by us

    Base
    $175,435
    Bonus
    $0
    Other
    $0
    Deferred
    $5,746
    Nontaxable benefits
    $21,315
    Filer's total
    $202,496

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation committee
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

PART I, LINE 3
APPROVED BY THE BOARD OF DIRECTORS. THE BOARD'S EXECUTIVE COMMITTEE CONDUCTS A MARKET SURVEY OF THE POSITION USING INDEPENDENT COMPENSATION SOURCES, AND THEN PRESENTS A RECOMMENDATION TO THE FULL BOARD FOR APPROVAL.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Fundraising and gaming

From Schedule G of this return, as filed.

Had an agreement with a professional fundraiser (line 2a)
Not answered

Fundraising events (Part II)

Part II has at most four columns: the two largest events, the rest together, and the total.

Fundraising events (Part II)
Line Event 1 CURE FOR CASEY Event 2 HOPE ON THE HILL Other events 48 events Total
Gross receipts (line 1) $265,339 $151,795 $2,922,301 $3,339,435
Less contributions (line 2) $256,088 $116,568 $2,257,560 $2,630,216
Gross income (line 3) $9,251 $35,227 $664,741 $709,219
Cash prizes (line 4) — — — —
Noncash prizes (line 5) $3,259 — $77,180 $80,439
Rent and facility costs (line 6) — $10,461 $38,242 $48,703
Food and beverages (line 7) $9,251 $35,227 $109,076 $153,554
Entertainment (line 8) $3,250 $682 $27,165 $31,097
Other direct expenses (line 9) $40,449 $12,906 $237,430 $290,785
Direct expenses (line 10)
$604,578
Net income (line 11)
$104,641

Activities outside the United States

From Schedule F of this return, as filed.

Offices (line 3c)
0
Employees, agents and contractors (line 3c)
0
Expenditures and investments (line 3c)
$565,669

At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.

Activities by region (Part I)

Activities by region (Part I)
Region Offices Employees Activity Specific services Expenditures
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 GRANTS TO RECIPIENTS IN THE REGION. GRANTS.LIST 59 _ 2AKOTLOVA - 10/23/24 09:18PM WORKSHEET FORM 990 - SCH F (PART I) _ 1372 $515,669
EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS IN THE REGION. GRANTS $50,000

Grants to organizations, by region (Part II)

The purpose of each grant is not shown.

Grants to organizations, by region (Part II)
Region Cash grants Manner of disbursement Noncash assistance Noncash description Valuation
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM $147,836 WIRE TRANSFER $0 — CASH VALUE
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM $364,960 WIRE TRANSFER $0 — CASH VALUE
EAST ASIA AND THE PACIFIC $50,000 WIRE TRANSFER $0 — CASH VALUE
Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
0
Other grantees (Part II line 3)
6
Transferred property to a foreign corporation during the year (line 1)
No
Had an interest in a foreign trust (line 2)
No
Owned an interest in a foreign corporation (line 3)
No
Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
No
Owned an interest in a foreign partnership (line 5)
No
Had operations in or related to a boycotting country (line 6)
No

Provenance

Return type
form_990
Tax year
2024
Filed
12 November 2025
IRS schema version
2024v5.2
Source object
202513169349304516

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.